On-Site Study Execution & Management

On-Site Study Execution & Management

Comprehensive coordination and execution of clinical studies to ensure protocol adherence and timely delivery. Our on-site execution services oversee the full trial lifecycle with a focus on protocol adherence, subject safety, and data integrity, guided by ICH GCP E6(R2) Section 5 (Sponsor Responsibilities, adapted for sites) and NDCT Rules, 2019 (Rule 20 on conduct). We minimize deviations through proactive coordination, ensuring ethical practices per ICMR Guidelines Section 8 (Informed Consent and Vulnerability). We specialize in cooperating with pharmaceutical, biotechnology, and medical device companies to conduct clinical research trials, integrate speedy patient enrollment solutions into clinical trials, and rescue delayed clinical trials/FDA submissions.
On-Site Study Execution & Management

Practical Guidelines and Support

Daily Operations

Manage informed consent (ICH GCP 4.8; ICMR 8.2) with multilingual forms; coordinate visits using calendars synced with EDC; ensure source data verification (SDV) per ALCOA+ principles (ICH GCP 4.9).

Safety and IP Management

Track AEs/SAEs within 24 hours (ICH GCP 4.11; NDCT Rule 31) via e-reporting to EC and sponsors; maintain IP logs (ICH GCP 4.6) with temperature-controlled storage.

Close-Out

Perform final data reconciliation (ICH GCP 4.13) and retention planning (NDCT Rule 35).

Site Initiation and Enrollment

Conduct initiation visits (ICH GCP 5.6.2) with protocol training; implement recruitment strategies like database screening (ICMR 8.3) targeting 80-90% enrollment goals.

Monitoring and Communication

Facilitate CRA visits (ICH GCP 5.18.3) with deviation logs; act as liaison for sponsor-CRO-EC queries, resolving issues within 48 hours.